Medicover AB Statistics

Total Valuation

Medicover AB has a market cap or net worth of GBP 2.78 billion. The enterprise value is 3.75 billion.

Market Cap	2.78B
Enterprise Value	3.75B

Important Dates

The next estimated earnings date is Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	74.35M
Shares Outstanding	n/a
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	50.84M

Valuation Ratios

The trailing PE ratio is 108.68 and the forward PE ratio is 46.67.

PE Ratio	108.68
Forward PE	46.67
PS Ratio	1.53
PB Ratio	6.53
P/TBV Ratio	n/a
P/FCF Ratio	22.43
P/OCF Ratio	12.28
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.30, with an EV/FCF ratio of 30.22.

EV / Earnings	146.46
EV / Sales	2.07
EV / EBITDA	16.30
EV / EBIT	49.79
EV / FCF	30.22

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 2.45.

Current Ratio	0.85
Quick Ratio	0.73
Debt / Equity	2.45
Debt / EBITDA	4.52
Debt / FCF	8.40
Interest Coverage	1.46

Financial Efficiency

Return on equity (ROE) is 5.12% and return on invested capital (ROIC) is 3.35%.

Return on Equity (ROE)	5.12%
Return on Assets (ROA)	2.70%
Return on Invested Capital (ROIC)	3.35%
Return on Capital Employed (ROCE)	5.60%
Revenue Per Employee	38,644
Profits Per Employee	545
Employee Count	47,256
Asset Turnover	1.04
Inventory Turnover	27.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.40% in the last 52 weeks. The beta is 1.56, so Medicover AB's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	+17.40%
50-Day Moving Average	222.10
200-Day Moving Average	198.96
Relative Strength Index (RSI)	56.47
Average Volume (20 Days)	2,076

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicover AB had revenue of GBP 1.82 billion and earned 25.60 million in profits. Earnings per share was 0.17.

Revenue	1.82B
Gross Profit	398.54M
Operating Income	75.46M
Pretax Income	31.37M
Net Income	25.60M
EBITDA	157.44M
EBIT	75.46M
Earnings Per Share (EPS)	0.17

Full Income Statement

Balance Sheet

The company has 90.35 million in cash and 1.04 billion in debt, giving a net cash position of -951.34 million.

Cash & Cash Equivalents	90.35M
Total Debt	1.04B
Net Cash	-951.34M
Net Cash Per Share	n/a
Equity (Book Value)	425.90M
Book Value Per Share	2.72
Working Capital	-70.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 226.63 million and capital expenditures -102.56 million, giving a free cash flow of 124.06 million.

Operating Cash Flow	226.63M
Capital Expenditures	-102.56M
Free Cash Flow	124.06M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.94%, with operating and profit margins of 4.15% and 1.41%.

Gross Margin	21.94%
Operating Margin	4.15%
Pretax Margin	1.73%
Profit Margin	1.41%
EBITDA Margin	8.67%
EBIT Margin	4.15%
FCF Margin	6.83%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.05%.

Dividend Per Share	0.13
Dividend Yield	0.05%
Dividend Growth (YoY)	24.44%
Years of Dividend Growth	n/a
Payout Ratio	58.82%
Buyback Yield	-0.35%
Shareholder Yield	-0.29%
Earnings Yield	0.92%
FCF Yield	4.46%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medicover AB has an Altman Z-Score of 2.04. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	n/a